Andreas Kümmel
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Heart Failure Treatment and Management 2
-
- Lung Cancer Treatments and Mutations 2
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- L. H. Schmidt (3 shared papers)Rainer Wiewrodt (2 shared papers)Dennis Görlich (2 shared papers)Michael Möhr (2 shared papers)Carsten Müller‐Tidow (1 shared paper)Anne M. Schultheis (1 shared paper)Wolfgang Hartmann (1 shared paper)Alessandro Marra (1 shared paper)
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (1 paper)The American Journal of Cardiology (1 paper)The FASEB Journal (1 paper)Immunology (1 paper)Diabetes Research and Clinical Practice (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Andreas Kümmel
8 papers receiving 334 citations
Peers
Comparison fields: 5 of 55
- Oncology 214
- Immunology 96
- Pulmonary and Respiratory Medicine 122
- Surgery 93
- Cancer Research 28
Countries citing papers authored by Andreas Kümmel
This map shows the geographic impact of Andreas Kümmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Kümmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Kümmel more than expected).
Fields of papers citing papers by Andreas Kümmel
This network shows the impact of papers produced by Andreas Kümmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Kümmel. The network helps show where Andreas Kümmel may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Kümmel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 197 | |
| 2 | 2006 | 83 | |
| 3 | Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue. | 2009 | 35 |
| 4 | 2010 | 13 | |
| 5 | 2022 | 6 | |
| 6 | 2019 | 5 | |
| 7 | 2022 | 2 | |
| 8 | 2018 | 1 |
About Andreas Kümmel
Andreas Kümmel is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Immunology, Oncology and Surgery, having authored 8 papers that have together received 342 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (2 papers), Heart Failure Treatment and Management (2 papers), Lung Cancer Treatments and Mutations (2 papers), interferon and immune responses (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Mechanical Circulatory Support Devices (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Oncology (214 citations), Immunology (96 citations), Pulmonary and Respiratory Medicine (122 citations), Surgery (93 citations) and Cancer Research (28 citations). Andreas Kümmel has collaborated with scholars based in Germany and United States. Frequent co-authors include L. H. Schmidt, Rainer Wiewrodt, Dennis Görlich, Michael Möhr, Carsten Müller‐Tidow, Anne M. Schultheis, Wolfgang Hartmann, Alessandro Marra, Eva Wardelmann and Inga Grünewald. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology, The FASEB Journal, Immunology and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.